BioNTech vs CureVac: European Patent Office declares CureVac mRNA patent valid Ruchika Sharma28 March 2025 5:11 PM ISTIn a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac valid.U.S.-listed shares of...
mRNA patent trial against BioNTech suspended by German court Ruchika Sharma29 Sept 2023 9:00 AM ISTDuesseldorf: A German court on Thursday suspended a patent trial against BioNTech over the use of mRNA technology in the COVID-19 vaccine developed by...
CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology Ruchika Sharma20 May 2023 3:29 PM ISTGermany: CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA...
Pfizer, BioNTech seek to revoke CureVac patent infringement claims Ruchika Sharma4 Sept 2022 4:51 PM ISTNew Delhi: Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their...
BioNTech, Pfizer sue CureVac in US over COVID jab patent claims Rahul Verma27 July 2022 6:00 PM ISTCOVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts,...
Pfizer, BioNTech sue CureVac in US over COVID vaccine patent claims Ruchika Sharma27 July 2022 4:44 PM ISTFrankfurt: COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in...
COVID vaccine: BioNTech faces patent lawsuit in Germany over use of MRNA technology Ruchika Sharma6 July 2022 5:00 PM ISTCureVac said that it was not seeking an injunction, nor intended to take legal action that would impede the production, sale or distribution of the...
COVID vaccine makers shift focus to booster shots Ruchika Sharma10 May 2022 11:00 AM ISTPfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...
GSK- CureVac experimental COVID variant vaccine effective in mice study Ruchika Sharma24 April 2022 9:15 AM ISTFrankfurt: CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly...
Examining to aid CureVac with experimental COVID-19 vaccine: Bayer CEO Ruchika Sharma19 Jan 2021 10:00 AM ISTBerlin: German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive...
CureVac anticipates to produce COVID-19 vaccine at scale by 2020 end Ruchika Sharma6 Sept 2020 10:00 AM ISTGermany: German biotech company Curevac expects to be able to produce the COVID-19 vaccine it is developing at scale by the end of the year,...
CureVac to raise over Rs 1834 crore IPO in US Ruchika Sharma11 Aug 2020 10:00 AM ISTFrankfurt: CureVac, one of Germany's leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial...
